Drug Policy Archives

Proposed Model Policy: “Veterans Mental Health Innovations Act”

Backgrounder by Kaitlyn Boecker, Geoffrey Lawrence and Leonard Gilroy

Model legislation would authorize groundbreaking research into ibogaine for mental health

Backgrounder by Aubri Strachan, Geoffrey Lawrence and Leonard Gilroy

Ibogaine could transform public spending on opioid treatment

Backgrounder by Madison Carlino

FAQ: Timeline for FDA ibogaine approval

FAQ by Gregory Ferenstein

Ibogaine and veterans’ mental health

Backgrounder by Aubri Strachan

Ibogaine offers breakthrough treatment for mental health, addiction, and TBIs

Backgrounder by Aubri Strachan

Harm reduction: An evidence-based approach to the drug war

Policy Brief by Layal Bou Harfouch

The truth about marijuana, mental illness, and violence: A review of Alex Berenson’s claims in ‘Tell Your Children’

Policy Study by Jacob James Rich and Robert Capodilupo

Drug decriminalization in Oregon: Measure 110’s impacts compared to other countries’ systems

Policy Brief by Nathan Daigneault

Ibogaine offers major promise in treating addiction, mental health

Backgrounder by Madison Carlino and Leonard Gilroy

Optimal framework for the state regulation of hemp cannabinoids

Backgrounder by Michelle Minton and Geoffrey Lawrence

Legalizing psilocybin access in Arizona would benefit mental health

Backgrounder by Leonard Gilroy and Geoffrey Lawrence

Psychedelic treatment for neurodegenerative disorders

Policy Brief by Madison Carlino

Psychedelic drug policy recommendations for the incoming Trump administration

Backgrounder by Geoffrey Lawrence, Leonard Gilroy and Gregory Ferenstein

More Drug Policy